EUVIMEDEUVIMED entdecken
Crossref

Obacunone inhibits RIPK1/RIPK3/MLKL-mediated necroptosis by suppressing mitochondrial ROS and MIF signaling in intestinal ischemia-reperfusion injury

Xiao-Yao Li, Jing-Yuan Xie, Yu-Tong Yin, Xiao-Guo Weng, Zi-Yi Huang, Lu-Si Wang, Ke Ding, Rong Chen, Qing-Tao Meng

International Immunopharmacology · 2026

DOI: 10.1016/j.intimp.2025.115901 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Xiao-Yao Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Reperfusion Injury, Macrophage Migration-Inhibitory Factors, Limonins. Die Arbeit nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Intestinal ischemia-reperfusion (IIR) is a critical pathophysiological event associated with high morbidity and mortality, often leading to intestinal barrier disruption and systemic inflammatory responses. Obacunone (OBA), a naturally occurring limonoid compound with documented antioxidant and anti-inflammatory properties, has not been previously studied in the context of IIR. This study aimed to evaluate its protective effects against IIR-induced damage. METHODS: In vivo IIR mouse models and in vitro IEC-6 cell models subjected to oxygen-glucose deprivation/reoxygenation (OGD/R) were used to assess the protective effects of OBA. Histological analysis, immunohistochemistry, immunofluorescence and western blotting were performed to evaluate tissue injury and necroptosis. Mitochondrial function and ROS production were assessed by JC-1 staining, MitoSOX fluorescence, and transmission electron microscopy. Network pharmacology and molecular docking were employed to identify potential OBA targets, followed by pharmacological validation using the MIF inhibitor ISO-1 and recombinant MIF protein. RESULTS: OBA pre-treatment significantly alleviated IIR-induced intestinal damage, restored epithelial integrity, and suppressed the phosphorylation of RIPK1, RIPK3, and MLKL. OBA attenuated ROS accumulation, suppressed mitochondrial ROS (mtROS) production, and preserved mitochondrial morphology and membrane potential, thereby suppressing necroptosis. Network pharmacology and molecular docking identified macrophage migration inhibitory factor (MIF) as a potential target of OBA. MIF inhibition mimicked OBA's protective effects, whereas exogenous MIF partially reversed them, indicating that OBA suppresses necroptosis via dual regulation of mtROS and MIF signaling. CONCLUSION: OBA protects against IIR-induced epithelial injury partly through modulation of mtROS- and MIF-driven necroptosis, providing a promising therapeutic strategy for intestinal ischemia-reperfusion injury and related inflammatory disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryMacrophage Migration-Inhibitory FactorsLimoninsAnimalsReactive Oxygen SpeciesNecroptosisReceptor-Interacting Protein Serine-Threonine KinasesMitochondriaMiceSignal TransductionProtein KinasesMaleCell LineRatsMice, Inbred C57BLIntestines

Stichwörter der Autor:innen

Intestinal ischemia-reperfusion injuryMIFNecroptosisNetwork pharmacologyObacunonemtROS

Substanzen

Reactive Oxygen SpeciesReceptor-Interacting Protein Serine-Threonine KinasesMacrophage Migration-Inhibitory FactorsProtein KinasesLimoninsRipk3 protein, mouseMLKL protein, mouseRipk1 protein, mouse

Autor:innen und Institutionen

  • Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, China.
  • Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, China; Department of Anesthesiology, East Hospital, Renmin Hospital of Wuhan University, Wuhan, China.
  • Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, China; Department of Anesthesiology, East Hospital, Renmin Hospital of Wuhan University, Wuhan, China. Electronic address: mengqingtao2018@126.co…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, X. Y., Xie, J. Y., Yin, Y. T., Weng, X. G., Huang, Z. Y., Wang, L. S., Ding, K., Chen, R., & Meng, Q. T. (2026). Obacunone inhibits RIPK1/RIPK3/MLKL-mediated necroptosis by suppressing mitochondrial ROS and MIF signaling in intestinal ischemia-reperfusion injury. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115901

Vancouver

Li XY, Xie JY, Yin YT, Weng XG, Huang ZY, Wang LS, et al. Obacunone inhibits RIPK1/RIPK3/MLKL-mediated necroptosis by suppressing mitochondrial ROS and MIF signaling in intestinal ischemia-reperfusion injury. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2025.115901

BibTeX
@article{Li2026,
  author = {Li, Xiao-Yao and Xie, Jing-Yuan and Yin, Yu-Tong and Weng, Xiao-Guo and Huang, Zi-Yi and Wang, Lu-Si and Ding, Ke and Chen, Rong and Meng, Qing-Tao},
  title = {Obacunone inhibits RIPK1/RIPK3/MLKL-mediated necroptosis by suppressing mitochondrial ROS and MIF signaling in intestinal ischemia-reperfusion injury},
  journal = {International Immunopharmacology},
  year = {2026},
  doi = {10.1016/j.intimp.2025.115901}
}
Kostenlos starten →